NCT04425161

Brief Summary

The high ratio of "central venous to arterial carbon dioxide" to "arterial to central venous oxygen content " is associated with elevated lactate in patients with septic shock. So, the aim of the present study is to evaluate the ratio of "central venous-to-arterial CO2 tension or content" to "arterial-to-venous O2 content'' as an indicator of anaerobic metabolism in septic shock.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 6, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 11, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

July 20, 2020

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

August 23, 2021

Status Verified

August 1, 2021

Enrollment Period

1.4 years

First QC Date

June 6, 2020

Last Update Submit

August 20, 2021

Conditions

Keywords

sepsisPCO2 gapPCO2 gap/ O2 content gap

Outcome Measures

Primary Outcomes (1)

  • Evaluation of the change of the ratio of "central venous-to-arterial CO2 tension or content" to "arterial-to-central venous O2 content" as an effective marker to indicate anaerobic metabolism in septic shock.

    To evaluate the change of the ratio of "central venous-to-arterial CO2 tension or content" to "arterial-to-central venous O2 content" between immediately before and Immedialey after volume expansion to indicate anaerobic metabolism in septic shock.

    Measurements will be taken immediately before and immediately after volume expansion

Study Arms (2)

VO2 ≥15 %

This group is classified based on increased oxygen consumption (VO2) ≥15 % by volume expansion in fluid responders

Other: Fluid challenge (0.9 % NaCl)

VO2 <15 %

This group is classified based on increased oxygen consumption (VO2) \< 15 % by volume expansion in fluid responders

Other: Fluid challenge (0.9 % NaCl)

Interventions

500 ml Fluid challenge of (0.9 % NaCl) will be given

VO2 <15 %VO2 ≥15 %

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Critically ill patients who will be admitted to intensive care units and eligible for the study.

You may qualify if:

  • Age \>18 years.
  • Suspected infection focus
  • Mean blood pressure \<65 mmHg, or required vasopressor infusion.
  • Lactic acid level \>2 mmol/l.
  • Mechanically ventilated patients.

You may not qualify if:

  • Age equal or less than 18 years.
  • Pregnant women.
  • Liver cirrhosis Child-Pugh C.
  • Chronic obstructive pulmonary disease.
  • Previous episode of septic shock within the last 3 months.
  • Patients with a contraindication to volume expansion.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AinShams

Cairo, Egypt

Location

MeSH Terms

Conditions

Shock, SepticSepsis

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Officials

  • Ahmed A Elsawy, Master

    Ain Shams University

    PRINCIPAL INVESTIGATOR
  • Ayman M Kamaly, Professor

    Ain Shams University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 6, 2020

First Posted

June 11, 2020

Study Start

July 20, 2020

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

August 23, 2021

Record last verified: 2021-08

Locations